Non-Surgical, Next Generation Cryoablation Technology- A Boon for Cancer Patients
Mumbai (Maharashtra) [India], June 9: Cancer patients in India can now heave a sigh of relief, thanks to the availability of cryoablation technology in the country. Cryoablation is a minimally invasive image-guided (ultrasound or CT scan) treatment that uses extreme cold to freeze and accurately destroy diseased tissue within the tumour zone. This technology is the brainchild of […]

Mumbai (Maharashtra) [India], June 9: Cancer patients in India can now heave a sigh of relief, thanks to the availability of cryoablation technology in the country. Cryoablation is a minimally invasive image-guided (ultrasound or CT scan) treatment that uses extreme cold to freeze and accurately destroy diseased tissue within the tumour zone. This technology is the brainchild of an Israeli company, IceCure Medical. Its flagship product, Pro-Sense, freezes tumours quickly and with minimal pain. It uses liquid nitrogen (LN2) for maximum freezing, safety, and efficacy. NovoMed Incorporation Pvt Ltd is the authorized distributor of IceCure Medical in India.
During cryoablation, a thin, needle-like probe called a cryoprobe is inserted into the target area. The cryoprobe uses liquid nitrogen as a coolant, which rapidly cools the surrounding tissue. As the tissue freezes, ice crystals form, causing cellular damage and destruction. Extreme cold temperatures essentially freeze and kill abnormal cells.
Cryoablation has several advantages over other treatment methods. It is considered a minimally invasive procedure, meaning it requires only a small incision or needle puncture, resulting in less trauma to the body and faster recovery times compared to open surgery. It can be performed under local anaesthesia, eliminating the need for general anaesthesia in many cases. Additionally, cryoablation is relatively precise, allowing for targeted treatment of the abnormal tissue while preserving surrounding healthy tissue. A hospital stay is not required in most cases.